妊娠中の糖尿病の予測因子として,第1 trimesterの完全な血液検査:多センターの初等保健医療研究
Abdullah M Alzahrani1,2,3, Noor S Alharbi3, Nourah Alageel3
1College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, SAU.
Cureus
|September 2, 2025
まとめ
妊娠中の中性粒子の数は妊娠中の糖尿病 (GDM) を予測できません. 母親の年齢やBMIなどの伝統的なリスクファクターは GDMの発症の重要な予測因子です
科学分野:
- 産婦人科
- 内分泌学
- 血液学
背景:
- 妊娠中糖尿病 (GDM) は,妊婦と新生児に重大なリスクをもたらす一般的な妊娠合併症です.
- 早期にGDMを予測することは 適切な介入と改善された結果のために不可欠です
研究 の 目的:
- GDMの発症に対する最初の3ヶ月間の全血球数 (CBC) パラメータ,特に中性粒子の数を評価する.
- 妊娠中のGDMリスクの早期マーカーを特定する.
主な方法:
- 18歳から45歳の399人の妊婦を対象とした遡及コホート研究.
- 最初の3ヶ月間のCBCパラメータ,臨床データ,GDMスクリーニング結果の分析.
- tテスト,チ2テスト,バイナリロジスティック回帰を含む統計分析.
主要な成果:
- 25.6%の女性がGDMを発症した.
- 重要な予測要因には,母親の年齢の上昇,BMIの上昇,過剰な体重増加,以前のGDM歴が含まれていた.
- 最初の3ヶ月間の中性粒子の数と中性粒子のリンパ球比 (NLR) は有意な予測指標ではなかったが,高血糖と赤血球数がGDM群で観察された.
結論:
- 伝統的な危険因子 (母親の年齢,BMI,体重増加,GDM歴) はGDMの予測に不可欠です.
- 最初の3ヶ月間の中性粒子の数はGDMの予測値に欠けており,早期の炎症マーカーとしての有用性が限られていることを示しています.
さらに関連する動画
06:11Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
762
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
2.7K
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Symptoms, Diagnosis, and Complications
685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
